Skip to main content
PMC home page
Heart logoLink to Heart
. 1997 Apr;77(4):309–313. doi: 10.1136/hrt.77.4.309

Heart failure and atrial fibrillation: current concepts and controversies.

M P Van den Berg 1, A E Tuinenburg 1, H J Crijns 1, I C Van Gelder 1, A T Gosselink 1, K I Lie 1
PMCID: PMC484722  PMID: 9155607

Abstract

Heart failure and atrial fibrillation are very common, particularly in the elderly. Owing to common risk factors both disorders are often present in the same patient. In addition, there is increasing evidence of a complex, reciprocal relation between heart failure and atrial fibrillation. Thus heart failure may cause atrial fibrillation, with electromechanical feedback and neurohumoral activation playing an important mediating role. In addition, atrial fibrillation may promote heart failure; in particular, when there is an uncontrolled ventricular rate, tachycardiomyopathy may develop and thereby heart failure. Eventually, a vicious circle between heart failure and atrial fibrillation may form, in which neurohumoral activation and subtle derangement of rate control are involved. Treatment should aim at unloading of the heart, adequate control of ventricular rate, and correction of neurohumoral activation. Angiotensin converting enzyme inhibitors may help to achieve these goals. Treatment should also include an attempt to restore sinus rhythm through electrical cardioversion, though appropriate timing of cardioversion is difficult. His bundle ablation may be used to achieve adequate rate control in drug refractory cases.

Full text

PDF
309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benjamin E. J., Levy D., Vaziri S. M., D'Agostino R. B., Belanger A. J., Wolf P. A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994 Mar 16;271(11):840–844. [PubMed] [Google Scholar]
  2. Brignole M., Gianfranchi L., Menozzi C., Bottoni N., Bollini R., Lolli G., Oddone D., Gaggioli G. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol. 1994 Aug 1;74(3):242–246. doi: 10.1016/0002-9149(94)90364-6. [DOI] [PubMed] [Google Scholar]
  3. Edner M., Caidahl K., Bergfeldt L., Darpö B., Edvardsson N., Rosenqvist M. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J. 1995 Sep;74(3):261–267. doi: 10.1136/hrt.74.3.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Flaker G. C., Blackshear J. L., McBride R., Kronmal R. A., Halperin J. L., Hart R. G. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 1992 Sep;20(3):527–532. doi: 10.1016/0735-1097(92)90003-6. [DOI] [PubMed] [Google Scholar]
  5. Goldenberg I. F., Lewis W. R., Dias V. C., Heywood J. T., Pedersen W. R. Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure. Am J Cardiol. 1994 Nov 1;74(9):884–889. doi: 10.1016/0002-9149(94)90580-0. [DOI] [PubMed] [Google Scholar]
  6. Gosselink A. T., Bijlsma E. B., Landsman M. L., Crijns H. J., Lie K. I. Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation. A 2-year follow-up. Eur Heart J. 1994 Oct;15(10):1368–1372. doi: 10.1093/oxfordjournals.eurheartj.a060396. [DOI] [PubMed] [Google Scholar]
  7. Gosselink A. T., Crijns H. J., Hamer H. P., Hillege H., Lie K. I. Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease. J Am Coll Cardiol. 1993 Nov 15;22(6):1666–1672. doi: 10.1016/0735-1097(93)90593-p. [DOI] [PubMed] [Google Scholar]
  8. Grogan M., Smith H. C., Gersh B. J., Wood D. L. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992 Jun 15;69(19):1570–1573. doi: 10.1016/0002-9149(92)90705-4. [DOI] [PubMed] [Google Scholar]
  9. Heinz G., Siostrzonek P., Kreiner G., Gössinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol. 1992 Feb 15;69(5):489–492. doi: 10.1016/0002-9149(92)90991-7. [DOI] [PubMed] [Google Scholar]
  10. Ho K. K., Anderson K. M., Kannel W. B., Grossman W., Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993 Jul;88(1):107–115. doi: 10.1161/01.cir.88.1.107. [DOI] [PubMed] [Google Scholar]
  11. Hofmann T., Meinertz T., Kasper W., Geibel A., Zehender M., Hohnloser S., Stienen U., Treese N., Just H. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J. 1988 Dec;116(6 Pt 1):1455–1463. doi: 10.1016/0002-8703(88)90728-4. [DOI] [PubMed] [Google Scholar]
  12. Kannel W. B., Abbott R. D., Savage D. D., McNamara P. M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982 Apr 29;306(17):1018–1022. doi: 10.1056/NEJM198204293061703. [DOI] [PubMed] [Google Scholar]
  13. Keogh A. M., Baron D. W., Hickie J. B. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol. 1990 Apr 1;65(13):903–908. doi: 10.1016/0002-9149(90)91434-8. [DOI] [PubMed] [Google Scholar]
  14. Klein L. S., Miles W. M., Zipes D. P. Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure, and refractory period. Contraction-excitation feedback in human atrium. Circulation. 1990 Jul;82(1):60–68. doi: 10.1161/01.cir.82.1.60. [DOI] [PubMed] [Google Scholar]
  15. Likoff M. J., Chandler S. L., Kay H. R. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 1987 Mar 1;59(6):634–638. doi: 10.1016/0002-9149(87)91183-0. [DOI] [PubMed] [Google Scholar]
  16. Middlekauff H. R., Stevenson W. G., Stevenson L. W. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation. 1991 Jul;84(1):40–48. doi: 10.1161/01.cir.84.1.40. [DOI] [PubMed] [Google Scholar]
  17. Pinto Y. M., Buikema H., van Gilst W. H. Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypotheses. Clin Exp Hypertens. 1995 Apr;17(3):441–468. doi: 10.3109/10641969509037418. [DOI] [PubMed] [Google Scholar]
  18. Platia E. V., Michelson E. L., Porterfield J. K., Das G. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol. 1989 Apr 15;63(13):925–929. doi: 10.1016/0002-9149(89)90141-0. [DOI] [PubMed] [Google Scholar]
  19. Rodriguez L. M., Smeets J. L., Xie B., de Chillou C., Cheriex E., Pieters F., Metzger J., den Dulk K., Wellens H. J. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol. 1993 Nov 15;72(15):1137–1141. doi: 10.1016/0002-9149(93)90982-i. [DOI] [PubMed] [Google Scholar]
  20. Rosenquvist M., Lee M. A., Moulinier L., Springer M. J., Abbott J. A., Wu J., Langberg J. J., Griffin J. C., Scheinman M. M. Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol. 1990 Nov;16(6):1467–1474. doi: 10.1016/0735-1097(90)90394-5. [DOI] [PubMed] [Google Scholar]
  21. Sanfilippo A. J., Abascal V. M., Sheehan M., Oertel L. B., Harrigan P., Hughes R. A., Weyman A. E. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation. 1990 Sep;82(3):792–797. doi: 10.1161/01.cir.82.3.792. [DOI] [PubMed] [Google Scholar]
  22. Seino Y., Shimai S., Ibuki C., Itoh K., Takano T., Hayakawa H. Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: endocrinologic silence. J Am Coll Cardiol. 1991 Aug;18(2):459–463. doi: 10.1016/0735-1097(91)90601-5. [DOI] [PubMed] [Google Scholar]
  23. Solti F., Vecsey T., Kékesi V., Juhász-Nagy A. The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc Res. 1989 Oct;23(10):882–886. doi: 10.1093/cvr/23.10.882. [DOI] [PubMed] [Google Scholar]
  24. Twidale N., Sutton K., Bartlett L., Dooley A., Winstanley S., Heddle W., Hassam R., Koutsounis H. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol. 1993 Jun;16(6):1275–1284. doi: 10.1111/j.1540-8159.1993.tb01714.x. [DOI] [PubMed] [Google Scholar]
  25. Van Den Berg M. P., Crijns H. J., Van Veldhuisen D. J., Griep N., De Kam P. J., Lie K. I. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail. 1995 Dec;1(5):355–363. doi: 10.1016/s1071-9164(05)80004-1. [DOI] [PubMed] [Google Scholar]
  26. Van Gelder I. C., Crijns H. J., Blanksma P. K., Landsman M. L., Posma J. L., Van Den Berg M. P., Meijler F. L., Lie K. I. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 1993 Sep 1;72(7):560–566. doi: 10.1016/0002-9149(93)90352-d. [DOI] [PubMed] [Google Scholar]
  27. Van Gelder I. C., Crijns H. J., Van Gilst W. H., Verwer R., Lie K. I. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991 Jul 1;68(1):41–46. doi: 10.1016/0002-9149(91)90707-r. [DOI] [PubMed] [Google Scholar]
  28. Vaziri S. M., Larson M. G., Benjamin E. J., Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994 Feb;89(2):724–730. doi: 10.1161/01.cir.89.2.724. [DOI] [PubMed] [Google Scholar]
  29. van den Berg M. P., Crijns H. J., Gosselink A. T., van den Broek S. A., Hillege H. J., van Veldhuisen D. J., Lie K. I. Chronotropic response to exercise in patients with atrial fibrillation: relation to functional state. Br Heart J. 1993 Aug;70(2):150–153. doi: 10.1136/hrt.70.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van den Berg M. P., van Veldhuisen D. J., Crijns H. J., Lie K. I. Reversion of tachycardiomyopathy after beta-blocker. Lancet. 1993 Jun 26;341(8861):1667–1667. doi: 10.1016/0140-6736(93)90808-t. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES